Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer | NEJM - nejm.org

6/5/2022 12:00:00 AM2 years 11 months ago

Original Article from The New England Journal of Medicine — Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

From the Memorial Sloan Kettering Cancer Center, New York (S.M.); Institut du Cancer de Montpellier, Université Montpellier, INSERM Unité 1194, Montpellier (W.J.), and Institut Curie, Université Pari… [+2622 chars]

full article...